Caribou Biosciences, Inc. (CRBU) Free cash flow 2019–2025
Caribou Biosciences, Inc. (CRBU) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$112.4MFY2025 · since FY2019: -$32.9M → -$112.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$112.4M | +21.5% |
| FY2024 | -$143.1M | -36.4% |
| FY2023 | -$104.9M | -7.7% |
| FY2022 | -$97.4M | -181.2% |
| FY2021 | -$34.6M | -3.3% |
| FY2020 | -$33.5M | -2.0% |
| FY2019 | -$32.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CRBU financial trends
CRBU RevenueCRBU Net incomeCRBU Net marginCRBU Gross profitCRBU Gross marginCRBU Operating incomeCRBU Operating marginCRBU Operating cash flowCRBU Capital expendituresCRBU Return on equityCRBU Stock buybacksCRBU Dividends paidCRBU Total assetsCRBU Total liabilitiesCRBU Shareholders’ equityCRBU overview →